Feasibility of Electromagnetic Acoustic Imaging of Liver Tumours

NAUnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

May 31, 2017

Conditions
Liver Tumours
Interventions
DEVICE

Electromagnetic Acoustic Imaging

Electromagnetic Acoustic imaging (EMA) is a novel experimental platform utilizing the combination of electromagnetic radio frequency (RF) and acoustic waves to enhance ultrasound images. The resultant imaging allows (based on early experimental models) tissue differentiation based on its mechanical and electrical properties. Combined with conventional US scanning, this technology potentially allows high spatial resolution imaging of a target tissue with superimposed high contrast functional information. This is a proof-of-concept pilot study in humans.

Trial Locations (1)

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Sunnybrook Health Sciences Centre

OTHER

lead

Enhanced Medical

INDUSTRY

NCT02827786 - Feasibility of Electromagnetic Acoustic Imaging of Liver Tumours | Biotech Hunter | Biotech Hunter